je ppt
DESCRIPTION
Presentation made by Md. Kabiul Akhter Ali, VBD Consultant, Uttar Dinajpur, West BengalTRANSCRIPT
MD.KABIUL AKHTER ALI Vector Borne Disease Consultant
NVBDCP, NRHMDistrict Heath & Family Welfare Samiti
Uttar Dinajpur
OverviewEconomic impactHistoryEpidemiologyTransmissionClinical SignsDiagnosis and TreatmentDisease in HumansPrevention and ControlActions to Take/Program mode
Japanese EncephalitisFlaviviridae
FlavivirusThe name is derived from
the Latin ‘flavus’ Flavus means “yellow”
Refers to yellow fever virus
EnvelopedSingle stranded RNA virusMorphology not well defined
History1870s: Japan
“Summer encephalitis” epidemics1924: Great epidemic in Japan
6,125 human cases; 3,797 deaths1935: Virus first isolated
From a fatal human encephalitis case1938: Isolated from Culex tritaeniorhynchus1952: First evidence of J E1955:First case in India1958:First viral isolation in India1973:First outbreak inBankura/Burdwan1978:widespread occurance/monitoring NMEPInitiation of immunisation –killed mouse brain vaccine
Economic ImpactAnimals
Porcine High mortality in piglets
Equine Up to 5% mortality rate
Humans Cost for immunization and medical treatment
Geographic DistributionEndemic in temperate
and tropical regions of Asia
Reduced prevalence in Japan
Has not occurred in U.S.
Japan
China
Korea
Indonesia
India
Philippines
Morbidity/MortalitySwine
High mortality in pigletsDeath rare in adult pigs
EquineMorbidity: 2%, during an outbreakMortality: 5%
HumansMortality: 5-40%Serious neurologic sequelae: 45-70%
TransmissionVector-borne diseaseEnzootic cycle
Mosquitoes: Culex species Culex vishnuii/pseudovishnui/tritinorinchus Paddy fields
Reservoir/Amplifying hosts Pigs, bats Ardeid (wading) birds Possibly reptiles and amphibians
Incidental hosts Horses, humans,(dead end)
Global ProblemLeading cause of viral encephalitis3 billion live in endemic areas50000 cases reported annually10-15 thousand deaths annuallyINDIA-33o million live in endemic areas in
15 states/ut135 districts are affected
Clinical Signs: SwineIncubation period not knownExposure early in pregnancy more
harmful Birth of stillborn or mummified fetuses Piglets: Neurological signs, deathBoars: Infertility, swollen testicles
Post Mortem LesionsHorses
Non-specificNonsuppurative
meningoencephalitisSwine
Fetuses Mummified and dark in appearance Hydrocephalus Cerebellar hypoplasia Spinal hypomyelinogenesis
Differential DiagnosisEquine
Other viral encephalitides, Hendra, rabies, neurotoxins, toxic encephalitis
SwineMyxovirus-parainfluenza 1, coronavirus,
Menangle virus, porcine parvovirus
SamplingBefore collecting or sending any samples, the
proper authorities should be contacted
Samples should only be sent under secure conditions and to authorized laboratories to prevent the spread of the disease
DiagnosisClinical
Horses: Fever and CNS disease Swine: High number of stillborn piglets
Laboratory TestsDefinitive: Viral isolation
Blood, spinal cord, brain, CSFRise in titer
Neutralization, HI, IF, CF, ELISA Cross reactivity of Flaviviruses
Treatment No effective treatmentSupportive care
Clinical Signs-Humans
Incubation period: 5 to 15 daysMost asymptomatic or mild signsChildren < 15 years and Elderly
At highest risk for severe disease Elderly: High case fatality rate (30%) For every case 200-1000 undetected/asymptomatic
cases Disease clinical perspective divided into
mild/moderate/severe/asymptomatic cases
Clinical Signs: SevereAcute encephalitis
Headache, high fever, stiff neck, stuporSevere encephalitis
Paralysis, seizures, convulsions, coma, and death
Neuropsychiatric sequelae45-70% of survivors
In utero infection possibleAbortion of fetus
Post Mortem LesionsPan-encephalitisInfected neurons
scattered throughout CNS
Occasional microscopic necrotic foci
Thalamus generally severely affected
Diagnosis and TreatmentClinicalLaboratory Tests
Tentative diagnosis Antibody titer: HI, IFA, CF, ELISA JE-specific IgM in serum or CSF
Definitive diagnosis Virus isolation: CSF sample, brain
No specific treatmentSupportive care
Public Health SignificanceStrengthening of surveillanceCapacity building for diagnosis/case
management to reduce fatalityClinical laboratory support/adequacy of
medicines in hospitalsVector surveillance strengtheningFocused IEC for early reportingIncreasing indigenous capacity of vaccine
production
DisinfectionBiosafety Level 3 precautionsChemical
Ethanol, glutaraldehyde, formaldehydeSodium hypochlorite (bleach)Iodine, phenols, iodophors
PhysicalDeactivation at 133oF (for 30 minutes)Sensitive to ultraviolet light and gamma
radiation
PreventionVector control
Eliminate mosquito breeding areasAdult and larvae control( chemical larvicides,
Biolarvicides, larvivorous fish)Environmental management
VaccinationEquine and swineHumans
Personal protective measuresAvoid prime mosquito hours/IVMSpace spray-Fogging with pyrethrum/malathionUse of repellants /ITN/curtains
Prevention(Program mode)Strengthening JE surveillance- identifying
/setting of 50 sentinel sites12 Apex Referral laboratories(Diagnosis)Guidelines for AES/JE surveillanceVBD Control Surveillance Unit at BRD
Medical College GorakhpurSub office ROHFW Lucknow at GorakhpurNIV Pune unit at BRD Medical College
Gorakhpur(funded by GOI/ICMR)
VaccinationLive attenuated vaccine
Used in equine and swineSuccessful for reducing incidence
Inactivated vaccine (JE-VAX)/SA 14-14-2 Chinese-Single dose IM(Children 1-15 years)
Used for human beings 2006-11 districts in 4 states(Assam,Karnataka,WB &UP) 2007 – Expanded to 27 districts in 9 states 2008- 23 districts in 9 states covered Left out and new cohorts covered in routine
immunisation
THANK YOU